Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): Management with L-ornithine-L-aspartate and stent reduction

被引：6
|
作者：
Stadlbauer, Vanessa
Tauss, Josef
Portugaller, Horst R.
Stiegler, Philipp
Iberer, Florian
Stauber, Rudolf E.
机构：
[1] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria
[2] Med Univ Graz, Dept Radiol, Div Intervent Radiol, Graz, Austria
[3] Med Univ Graz, Dept Surg, Div Transplantat Surg, Graz, Austria
来源：
METABOLIC BRAIN DISEASE | 2007年 / 22卷 / 01期
关键词：
hepatic encephalopathy; venous ammonia levels; transjugular intrahepatic portosystemic shunt; L-ornithine-L-aspartate; stent reduction;
D O I：
10.1007/s11011-006-9032-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hepatic encephalopathy (HE) is a common problem after insertion of a transjugular intrahepatic portosystemic shunt (TIPS), which may be difficult to manage. We present a case of severe post-TIPS HE unresponsive to high doses of L-ornithine-L-aspartate (LOLA) despite reduction of venous ammonia levels in a dose-dependent fashion. Ultimately, high-grade HE was successfully treated by a reduction stent and the patient subsequently underwent successful liver transplantation.
引用
收藏
页码：45 / 50
页数：6
相关论文
共 50 条
  • [1] Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): Management with l-ornithine-l-aspartate and stent reduction
    Vanessa Stadlbauer
    Josef Tauss
    Horst R. Portugaller
    Philipp Stiegler
    Florian Iberer
    Rudolf E. Stauber
    Metabolic Brain Disease, 2007, 22 : 45 - 50
  • [2] Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy
    Kircheis, G
    Wettstein, M
    vom Dahl, S
    Häussinger, D
    METABOLIC BRAIN DISEASE, 2002, 17 (04) : 453 - 462
  • [3] L-Ornithine-L-aspartate in the management of hepatic encephalopathy: A meta-analysis
    Jiang, Qian
    Jiang, Xue-Hua
    Zheng, Ming-Hua
    Chen, Yong-Ping
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (01) : 9 - 14
  • [4] L-Ornithine-L-Aspartate Infusion Efficacy in Hepatic Encephalopathy
    Ahmad, Irfan
    Khan, Anwaar A.
    Alam, Altaf
    Dilshad, Akif
    Butt, Arshad Kamal
    Shafqat, Farzana
    Malik, Kashif
    Sarwar, Shahid
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2008, 18 (11): : 684 - 687
  • [5] Hepatic Encephalopathy following Transjugular Intrahepatic Portosystemic Shunt Placement
    Thornburg, Bartley
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2023, 40 (03) : 262 - 268
  • [6] Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
    Mamiya, Y
    Kanazawa, H
    Kimura, Y
    Narahara, Y
    Yamate, Y
    Nakatsuka, K
    Sakamoto, C
    HEPATOLOGY RESEARCH, 2004, 30 (03) : 162 - 168
  • [7] Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy
    Rossle, M
    Piotraschke, J
    DIGESTIVE DISEASES, 1996, 14 : 12 - 19
  • [8] Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
    Riggio, Oliviero
    Nardelli, Silvia
    Moscucci, Federica
    Pasquale, Chiara
    Ridola, Lorenzo
    Merli, Manuela
    CLINICS IN LIVER DISEASE, 2012, 16 (01) : 133 - +
  • [9] Unique Method of Transjugular Intrahepatic Portosystemic Shunt Reduction for Refractory Hepatic Encephalopathy
    Khan, Ayub
    Bailey, Christopher W.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [10] Efficacy of L-ornithine-L-aspartate as an Adjuvant Therapy in Cirrhotic Patients with Hepatic Encephalopathy
    Abid, Shahab
    Jafri, Wasim
    Mumtaz, Khalid
    Islam, Muhammad
    Abbas, Zaigham
    Shah, Hasnain Ali
    Hamid, Saeed
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (11): : 666 - 671
12345